Semaglutide, the active ingredient in diabetes medications Ozempic and Wegovy, was associated with a significantly reduced ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...

The research indicated that those with cataracts and systemic conditions were up to 2.29 times more likely to develop ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

The Southeast — Kentucky, Tennessee, Alabama and Mississippi — had a 25% higher dementia diagnosis rate compared to the ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...

One traditional Asian drink is becoming increasingly popular in the West due to its reported health benefits – and you can ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...